Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Knott David M Jr (CIK 1892770) reported $189.2M across 82 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: GOOG ($32.3M, 17.07%), APO ($26.6M, 14.07%), SNDX ($9.6M, 5.05%), XERS ($8.4M, 4.44%), TVTX ($8.4M, 4.42%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | GOOG | Alphabet Inc-Cl C | $32.3M | 17.07% | 91,420 | Hold |
| 2 | APO | Apollo Global Management, Inc. | $26.6M | 14.07% | 225,000 | Hold |
| 3 | SNDX | Syndax Pharmaceutical, Inc. | $9.6M | 5.05% | 437,245 | Added |
| 4 | XERS | Xeris Biopharma Holdings, Inc. | $8.4M | 4.44% | 1.1M | Hold |
| 5 | TVTX | Travere Therapeutics, Inc. | $8.4M | 4.42% | 147,282 | Added |
| 6 | PTGX | Protagonist Therapeutics, Inc | $7.7M | 4.08% | 63,000 | Hold |
| 7 | BBIO | Bridgebio Pharma, Inc. | $6.9M | 3.66% | 92,850 | Added |
| 8 | IOVA | Iovance Biotherapeutics, Inc. | $6.7M | 3.52% | 1.6M | Hold |
| 9 | ALKS | Alkermes PLC | $6.4M | 3.37% | 121,759 | Added |
| 10 | JPM | JPMorgan Chase & Co. | $5.9M | 3.13% | 18,098 | Trimmed |
| 11 | JAAA | Janus Henderson AAA CLO ETF | $4.7M | 2.50% | 93,528 | Hold |
| 12 | LPL Financial Holdings Inc. | $4.6M | 2.46% | 16,500 | Hold | |
| 13 | COGT | Cogent Biosciences Inc. | $4.3M | 2.27% | 111,081 | Added |
| 14 | TGTX | TG Therapeutics, Inc. | $3.7M | 1.94% | 66,839 | Trimmed |
| 15 | CLST | Catalyst Pharmaceuticals, Inc. | $3.6M | 1.89% | 114,000 | New |
| 16 | AGIO | Agios Pharmaceutical, Inc. | $3.5M | 1.86% | 95,058 | Added |
| 17 | VRDN | Viridian Therapeutics, Inc. | $3.3M | 1.76% | 181,000 | Hold |
| 18 | RLMD | Relmada Therapeutics, Inc. | $3.1M | 1.65% | 451,000 | Added |
| 19 | RCUS | Arcus Biosciences, Inc. | $2.5M | 1.32% | 81,241 | Hold |
| 20 | HELP | Cybin Inc | $2.4M | 1.29% | 370,000 | Added |
| 21 | XBI | SPDR S&P Biotech ETF | $2.4M | 1.25% | 15,000 | Hold |
| 22 | RZLT | Rezolute, Inc. | $1.9M | 1.02% | 370,000 | Hold |
| 23 | AB | AllianceBernstein Holding L.P. | $1.7M | 0.89% | 48,000 | Hold |
| 24 | MDGL | Madrigal Pharmaaceuticals, Inc. | $1.6M | 0.85% | 3,000 | Added |
| 25 | ATRC | AtriCure, Inc. | $1.4M | 0.76% | 51,400 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30